LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Large Joints and Extremities/ConforMIS, Inc: Full Commercial Launch of iTotal PS
Large Joints and Extremities

ConforMIS, Inc: Full Commercial Launch of iTotal PS

March 16, 2016 2 min read Premium comments

Advertisement

ConforMIS, Inc: Full Commercial Launch of iTotal PS
iTotal PS Posterior View / Courtesy of ConforMIS, Inc.
Secondary

ConforMIS, Inc. has announced the full commercial launch of iTotal PS, the only customized posterior stabilized knee replacement system. Over 1, 000 patients have been treated by select orthopedic surgeons using the iTotal PS during the limited launch over the past 12 months.

According to the March 2, 2016 news release, “The ConforMIS iTotal PS was designed to address the shortcomings of traditional knee replacements, which come in a fixed set of sizes and shapes. The customized iTotal PS implant builds on the advantages of the iTotal CR system, first introduced in May 2011. The iTotal PS implants are customized for each patient to avoid overhang, rotation, and sizing compromises, common causes of pain after surgery. In addition, iTotal PS is designed to restore the natural shape of each patient’s knee and has a customized cam and spine to provide optimal stability throughout the full range of motion.”

“The full launch of the iTotal PS nearly triples our addressable market. We believe this launch is our single biggest commercial opportunity to date, ” said Philipp Lang, M.D., M.B.A., ConforMIS CEO and president. “With iTotal PS, we have now greatly expanded the number of patients who will be candidates for our customized knee replacement implants. We are very excited to bring the benefits of customized knee replacements to surgeons who prefer a posterior-stabilized design. Since we initiated our limited launch of iTotal PS last year, the feedback from surgeons has been extremely positive.”

Asked how they designed this such that there is no overhang or rotation, Dr. Lang told OTW, “It’s all about fit. The iTotal PS femoral and tibial components are customized for each patient to avoid overhang and under-coverage, and sizing compromises. There is a precise fit in all three femoral compartments, customized posterior fit to avoid overhang, anatomic tibial axis alignment and patient specific profile. It starts by recreating each patient’s unique femoral articulating surfaces. With iTotal, the patient’s anatomic j-curves provides the basis for the implant design, starting with a CT scan for each individual patient. For the iTotal PS design, the design of the cam and spine shape, location, and size are each customized to respect each patient’s unique j-curves throughout the range of motion to provide optimal stability, restore kinematics, reduce potential for a ‘mechanical’ feel.”

Adam Hayden, M.S., M.B.A., senior vice president, Marketing for ConforMIS, told OTW, “The iTotal PS approximately triples the available market for ConforMIS. Our sales organization is approaching this large opportunity in a disciplined and methodical way and we are prepared to execute on this significant growth opportunity. Following AAOS [American Academy of Orthopaedic Surgeons], our salesforce and medical education team will focus on educating and training new PS surgeons utilizing our well-established national training labs and our surgeon visitation program. ConforMIS hosted the first post-launch training lab during the Academy of Orthopedic Surgeons, and we are pleased to report it was a great success, and very well attended. These educational forums will be ongoing and offer surgeons the opportunity to have hands-on experience with the product alongside experienced ConforMIS users.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy